(Q35904408)

11 August 2017

1 reference

title

Immune responses to gene therapy vectors: influence on vector function and effector mechanisms (English)

1 reference

11 August 2017

0 references

Bessis N

1

1 reference

11 August 2017

GarciaCozar FJ

series ordinal

2

1 reference

11 August 2017

Boissier MC

series ordinal

3

1 reference

11 August 2017

publication date

1 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

11 Suppl 1

1 reference

11 August 2017

page(s)

S10-7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302364

11 August 2017

exact match

0 references

cites work

Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Virus treatment questioned after gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

B-lymphocytes in bone marrow or lymph nodes can take up plasmid DNA after intramuscular delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Complement activation by recombinant adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Recombinant adeno-associated virus for muscle directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Effect of adeno-associated virus-specific immunoglobulin G in human amniotic fluid on gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Immune responses to adeno-associated virus and its recombinant vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Development of adenovirus serotype 35 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Dendritic cells: controllers of the immune system and a new promise for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Influence of immunosuppressive drugs on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

inferred from DOI database lookup

7 January 2021

based on heuristic

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

inferred from DOI database lookup

7 January 2021

based on heuristic

Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302364

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302364

1 reference

Dimensions Publication ID

11 August 2017

1040355762

0 references

1 reference